Treatment of mild to moderate COVID-19 in patients who have been symptomatic for no more than 72 hours.
Children ≥12 years, Adolescents, and Adults: Oral: 375 mg once daily on day 1, followed by 125 mg once daily on days 2 to 5.
Product available in various countries; not currently available in the United States.
Tablet, Oral: 125 mg